return2ozma@lemmy.world to News@lemmy.world · 1 year agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square123fedilinkarrow-up1562arrow-down115
arrow-up1547arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 1 year agomessage-square123fedilink
minus-squareMarcbmann@lemmy.worldlinkfedilinkarrow-up2·edit-21 year agoNovo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.
Novo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.